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The NMDA and AMPA classes of ionotropic glutamate recep-
tors are concentrated at postsynaptic sites in excitatory syn-
apses. NMDA receptors interact via their NR2 subunits with
PSD-95/SAP90 family proteins, whereas AMPA receptors bind
via their GluR2/3 subunits to glutamate receptor-interacting
protein (GRIP), AMPA receptor-binding protein (ABP), and pro-
tein interacting with C kinase 1 (PICK1). We report here a novel
cDNA (termed ABP-L/GRIP2) that is virtually identical to ABP
except for additional GRIP-like sequences at the N-terminal
and C-terminal ends. Like GRIP (which we now term GRIP1),
ABP-L/GRIP2 contains a seventh PDZ domain at its C termi-
nus. Using antibodies that recognize both these proteins, we
examined the subcellular localization of GRIP1 and ABP-L/
GRIP2 (collectively termed GRIP) and their biochemical asso-
ciation with AMPA receptors. Immunogold electron microscopy
revealed the presence of GRIP at excitatory synapses and also
at nonsynaptic membranes and within intracellular compart-
ments. The association of native GRIP and AMPA receptors
was confirmed biochemically by coimmunoprecipitation from
rat brain extracts. A majority of detergent-extractable GluR2/3
was complexed with GRIP in the brain. However, only approx-
imately half of GRIP was associated with AMPA receptors.
Unexpectedly, immunocytochemistry of cultured hippocampal
neurons and rat brain at the light microscopic level showed
enrichment of GRIP in GABAergic neurons and in GABAergic
nerve terminals. Thus GRIP is associated with inhibitory as well
as excitatory synapses. Collectively, these findings support a
role for GRIP in the synaptic anchoring of AMPA receptors but
also suggest that GRIP has additional functions unrelated to the
binding of AMPA receptors.
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At excitatory synapses, ionotropic glutamate receptors of the
NMDA class are highly concentrated in the postsynaptic density
(PSD). The NR2 subunits of the NMDA receptors bind through
their C-terminal cytoplasmic tails to the PDZ domains of PSD-
95/SAP90 and related proteins, which are major components of
the PSD (Kornau et al., 1995; Müller et al., 1996; Niethammer et
al., 1996). The NR1 subunit of the NMDA receptor interacts with
a distinct set of intracellular proteins, including a-actinin
(Wyszynski et al., 1997), neurofilament-L (Ehlers et al., 1998),
and yotiao (Lin et al., 1998). The interaction between NMDA
receptors and PSD-95 family proteins may be important for the
localization of NMDA receptors at postsynaptic sites. In Dro-
sophila, the PSD-95 homolog Discs-large is essential for the syn-
aptic clustering of its PDZ binding partners Shaker and Fasciclin
II (Tejedor et al., 1997; Thomas et al., 1997; Zito et al., 1997). In
addition, because of its multidomain structure, PSD-95 can also
bind to several signaling and cytoskeletal proteins, including
neuronal nitric oxide synthase (Brenman et al., 1996), synGAP
(Chen et al., 1998; Kim et al., 1998), and CRIPT (Niethammer et
al., 1998), thereby potentially bringing these proteins together in
a complex (for review, see Craven and Bredt, 1998). By acting as
scaffold proteins, PSD-95 and related molecules can organize a
specific cytoskeletal-signaling complex that is physically linked to
the NMDA receptor.
Ionotropic glutamate receptors of the AMPA class (composed
of GluR1–4 subunits) are also concentrated at postsynaptic sites.
Although they largely colocalize with NMDA receptors in exci-
tatory synapses, AMPA receptors do not interact with PSD-95
family proteins. Instead, the AMPA receptor subunits GluR2/3
bind specifically to other PDZ proteins, termed glutamate
receptor-interacting protein (GRIP) (Dong et al., 1997), AMPA
receptor-binding protein (ABP) (Srivastava et al., 1998), and
protein interacting with C kinase 1 (PICK1) (Xia et al., 1999).
GRIP contains seven PDZ domains and no other recognizable
motif, in contrast to PSD-95, which has three PDZ domains plus
an Src homology 3 domain and a guanylate kinase-like domain.
ABP resembles GRIP in primary sequence; it differs from GRIP
most notably in lacking the C-terminal seventh PDZ domain. The
C-terminal sequence (-ESVKI) shared by AMPA receptor
GluR2/3 subunits is reported to bind selectively to the forth and
fifth PDZ domains (PDZ4/5) of GRIP (Dong et al., 1997) and the
third, fifth, and sixth PDZ domains of ABP (Srivastava et al.,
1998). However, neither Dong et al. (1997) nor Srivastava et al.
(1998) confirmed a biochemical association of GRIP and AMPA
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receptors in brain. We have recently found that GRIP is only
modestly enriched in the PSD fraction when compared with
PSD-95 (Wyszynski et al., 1998). These observations beg the
question of how substantially AMPA receptors interact with
GRIP and ABP in vivo.
We report here the cloning of a novel GRIP-like protein
(termed ABP-L/GRIP2) that is virtually identical to ABP but
that contains additional N-terminal and C-terminal sequences,
including a seventh PDZ domain. ABP and ABP-L/GRIP2 ap-
pear to be splice variants of the same gene containing six or seven
PDZ domains, respectively; thus the domain organizations, as
well as the primary sequence, of the ABP and GRIP genes are
highly conserved. We will henceforth use the term GRIP1 for the
original GRIP polypeptide described by Dong et al. (1997). Using
antibodies that recognize both GRIP1 and ABP-L/GRIP2 (these
related proteins collectively termed GRIP), we show a wider
subcellular distribution of these proteins in neurons than previ-
ously appreciated, including enrichment in GABAergic nerve
terminals. Using a semiquantitative coimmunoprecipitation assay,
we show that a majority of the detergent-extractable GluR2/3 is
complexed with GRIP in adult rat brain tissue; however, a con-
siderable fraction of GRIP is not associated with GluR2/3. Taken
together, these results show for the first time the biochemical
association of AMPA receptors and GRIP in vivo but suggest
additional functions for GRIP other than that of anchoring
AMPA receptors at synapses.
MATERIALS AND METHODS
Cloning of GRIP1 and ABP-L/GRIP2. Yeast two-hybrid screening was
performed as described previously using the L40 yeast strain harboring
HIS3 and b-galactosidase as reporter genes (Niethammer et al., 1996).
Approximately 2 3 10 6 clones were screened of a rat brain cDNA library
constructed in the GAL4 activation domain vector pGAD10 (Clontech,
Palo Alto, CA). The two-hybrid bait consisted of a C-terminal peptide,
-GRISYDL, fused to LexA (this peptide was an artifactual sequence
generated aberrantly during PCR construction of another bait). The
two-hybrid screen yielded multiple isolates of two distinct clones (clones
5 and 14). Clone 5 was a cDNA fragment of GRIP1, encoding amino
acids 363–1112 (containing PDZ4 through the C terminus). Clone 14
encoded amino acids 556–1002 of ABP-L/GRIP2 (beginning within
PDZ5 and extending through the C terminus). Additional GRIP1 and
ABP-L/GRIP2 cDNA sequences were obtained by hybridization screen-
ing of lZAP II rat cortical and hippocampal cDNA libraries (Stratagene,
La Jolla, CA) using as probes the GRIP1 and ABP-L/GRIP2 cDNA
fragments described above. The 59 ends of GRIP1 and ABP-L/GRIP2
were obtained by 59 rapid amplification of cDNA ends using a Marathon-
Ready rat brain cDNA library (Clontech). DNA sequences were ob-
tained by automated sequencing. The nucleotide sequence of ABP-L/
GRIP2 has been deposited in GenBank under accession number
AF112182
Northern blots. A rat poly-A mRNA multi-tissue Northern blot (Clon-
tech) was probed with 32P-labeled ABP-L/GRIP2 cDNA fragments
(corresponding to amino acids 556–1002) under high-stringency condi-
tions using ExpressHyb (Clontech) and exposed at 280°C on XAR-5
film (Eastman Kodak, Rochester, NY) for 50 hr.
Antibodies. GRIP antibodies (termed “1756” and “C8399”) were raised
by immunizing two different rabbits with a hexahistidine (H6 )-tagged
fusion protein incorporating GRIP1 amino acids 664–1112 (includes
PDZ6 and extends to the C terminus of the protein); 1756 antibodies
were then affinity-purified on a Sulfolink column (Pierce, Rockford, IL)
coupled to a soluble H6-tagged fusion protein of GRIP1 containing
PDZ4–PDZ6 (residues 463–761) and have been described (Wyszynski et
al., 1998). C8399-I antibodies were affinity-purified on a Sulfolink column
coupled to a soluble glutathione S-transferase fusion protein incorporat-
ing GRIP1 amino acids 664–1112. The rabbit anti-PSD-95 antibody
(CSK) has been previously described (Kim and Sheng, 1996). The
following antibodies were obtained from commercial sources: polyclonal
anti-GluR2/3 and monoclonal anti-GluR2-N antibodies (Chemicon, Te-
mecula, CA); anti-NR1 monoclonal antibody 54.1 (PharMingen, San
Diego, CA); anti-glutamic acid decarboxylase (GAD) monoclonal anti-
bodies (Boehringer Mannheim, Indianapolis, IN); anti-GAD-6 monoclo-
nal antibodies (Developmental Studies Hybridoma Bank, University of
Iowa, Iowa City, IA); and nonimmune purified rabbit IgG and anti-
synaptophysin monoclonal antibodies (Sigma, St. Louis, MO). The rabbit
and guinea pig anti-GluR1 antibodies were gifts from Richard L. Huganir
(Johns Hopkins University School of Medicine, Baltimore, MD).
Immunohistochemistry on brain and cultured neurons. Brain immuno-
histochemistry was performed on Vibratome-cut 50 mm floating brain
sections from Sprague Dawley rats (;6 weeks of age) perfused transcar-
diacally with 4% paraformaldehyde and treated with proteinase K as
described (Lin et al., 1998). Primary anti-GAD monoclonal antibodies
were used at 1 mg/ml. Hippocampal neuron cultures were prepared from
hippocampi dissected from embryonic day 18 rat embryos by the methods
of Banker and Cowan (1977) and Goslin and Banker (1991). Neurons
were fixed at 3 weeks in culture with 4% paraformaldehyde and 4%
sucrose in phosphate buffer, permeabilized with 0.25% Triton X-100, and
immunolabeled using mouse anti-GluR1, mouse anti-GluR2-N, mouse
anti-synaptophysin, or mouse anti-GAD-6 antibodies. All double label-
ing was performed with rabbit anti-GRIP antibody 1756 antibodies (1
mg/ml). Staining was visualized using Cy3- or FITC-conjugated second-
ary antibodies (Jackson ImmunoResearch, West Grove PA).
Immunoelectron microscopy. For electron microscopy, five Sprague
Dawley rats were perfusion-fixed with a mixture of 2–4% paraformal-
dehyde and 2% glutaraldehyde; brains were post-fixed for 2–4 hr. Fifty-
micrometer-thick transverse sections were cut on a Vibratome and pro-
cessed for osmium-free embedment (for details, see Phend et al., 1995).
Thin sections were cut and collected on 300-mesh uncoated nickel grids
and stained for GRIP using anti-GRIP1 antibodies C8399-I and 1756.
After treatment with 4% paraphenylenediamine in Tris-buffered saline
containing detergent (TBS/T; 0.1 M Tris, pH 7.6, with 0.005% Tergitol
NP-10) for 1 hr, grids were rinsed and incubated overnight at 37°C in
primary antibody (1:100), rinsed in TBS/T, pH 7.6, transferred to TBS/T,
pH 8.2, and incubated for 1 hr in the secondary antibody [goat anti-rabbit
IgG conjugated to 10 nm (Amersham, Arlington Heights, IL) or 18 nm
(E-Y Labs, San Mateo, CA) gold particles]. Grids were then rinsed and
counterstained with uranyl acetate and Sato’s lead. In control experi-
ments, in the absence of primary rabbit serum, virtually no gold particles
were detected; after exposure to nonimmune rabbit serum, sparse gold
particles were seen that showed no obvious pattern. Grids were examined
at 80 kV on a JEOL (Tokyo, Japan) 200CX electron microscope. For
quantitation, micrographs at 29,000–40,0003 original magnification
were digitized on a flat-bed scanner. Locations of gold particles were
measured using NIH Image software running on a Macintosh platform.
For each grid studied, the first 10 synapses with clearly visible synaptic
structures, labeled with at least one gold particle within 100 nm on either
side of the postsynaptic membrane, were considered. To define “axoden-
dritic” position, we measured the distance between the center of each
gold particle and the outer leaflet of the postsynaptic membrane. To
define “lateral” synaptic position, we measured the distance from each
end of the active zone to a line drawn perpendicular to the synapse
running through the center of the particle.
Immunoprecipitation. Coimmunoprecipitation of GRIP, GluR2/3, and
GluR1 complexes from rat cortex was done on sodium deoxycholate
(DOC)-extracted rat brain membranes as described (Luo et al., 1997). In
brief, DOC extracts were prepared by resuspending rat brain cortex P2
fraction in a suitable volume (1 ml/gm of tissue) of ice-cold Tris-EDTA
buffer (10 mM Tris-HCl and 5 mM EDTA, pH 7.4) and sonicated briefly.
One-tenth volume of ice-cold DOC buffer (10% sodium deoxycholate
and 500 mM Tris-HCl, pH 9.0) was added to the sonicate, followed by
incubation at 36°C for 30 min. After the addition of 0.1 volume of Triton
X-100 buffer (1% Triton X-100 and 500 mM Tris-HCl, pH 9.0), the
samples were dialyzed against ice-cold binding buffer (50 mM Tris-HCl,
pH 7.4, and 0.1% Triton X-100). Unextractable material was pelleted at
37,000 3 g for 40 min, and the supernatant was used for
immunoprecipitation.
For immunoprecipitation, GRIP (C8399-I), GluR2/3, GluR2-N, or
rabbit IgG antibodies were prebound to protein A-Sepharose beads by
incubating the antibodies with protein A-Sepharose beads (Sigma) at a
ratio of 20 mg of antibodies/40 ml of protein A-Sepharose beads in 200
mM Na-borate buffer, pH 8.0, at 4°C for 12 hr. The protein A-Sepharose/
antibody-bound beads were then washed with 200 mM Na-borate buffer,
pH 9.0, added to 100 mg of DOC-extracted protein (see above), and
allowed to incubate at 4°C for 2–3 hr. The immunoprecipitation reaction
was then centrifuged at high speed in a microcentrifuge; the supernatant
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Figure 1. Top, Amino acid sequence
alignment of GRIP1 and ABP-L/GRIP2.
The third line (Cons.) shows the consensus
amino acids that are common between
GRIP1 and ABP-L/GRIP2. The seven
PDZ domains are underlined. Bottom, Rat
poly-A mRNA Northern blot showing the
tissue distribution of ABP-L/GRIP2 mR-
NAs. Positions of RNA molecular size
markers are shown in kilobases.
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was saved, and the immunoprecipitate pellet was washed three times with
binding buffer.
RESULTS
Cloning of ABP-L/GRIP2, a splice variant of ABP
containing seven PDZ domains
By yeast two-hybrid screening (see Materials and Methods), we
obtained not only multiple isolates of a cDNA fragment (clone 5)
from the original GRIP gene (Dong et al., 1997; GRIP1) but also
a cDNA fragment (clone 14) that we subsequently found to be
virtually identical to ABP within the region of overlap (Srivastava
et al., 1998). We obtained the full-length coding sequence of this
ABP-related gene, which showed interesting differences from the
full-length ABP sequence published by Srivastava et al. (1998).
Compared with ABP, our open reading frame contained an
N-terminal extension of 52 amino acids, an internal deletion of 41
amino acids between PDZ3 and PDZ4, and a C-terminal exten-
sion that contains an additional seventh PDZ domain (PDZ7; Fig.
1). Otherwise, the two proteins are essentially identical, suggest-
ing that the extensions and deletions noted in our clone arise
from differential splicing. We called the novel protein encoded by
our cDNA “ABP-L/GRIP2,” because it is a longer splice variant
of ABP, and because it is clearly a close relative of GRIP1 (Dong
et al., 1997), both in terms of primary sequence and domain
organization. Because ABP is essentially contained within ABP-
L/GRIP2, we presume that ABP and ABP-L/GRIP2 are splice
variants of the same gene. In this paper, we use the name GRIP1
for the original GRIP described by Dong et al. (1997) and
ABP-L/GRIP2 for the long splice variant of ABP. The generic
term GRIP will be used to refer to GRIP1 and ABP-L/GRIP2
proteins as a set.
Over its entire length, ABP-L/GRIP2 is 56% identical and
68% similar to GRIP1 at the amino acid level (Fig. 1). The
greatest similarity between GRIP1 and ABP-L/GRIP2 occurs
over the respective PDZ domains 1–7, with highest identity for
PDZ6 (93%) and lowest identity for PDZ3 (62%). There is also
significant homology between GRIP1 and ABP-L/GRIP2 in the
intervening sequences between each PDZ domain. During the
cloning and sequencing of overlapping cDNAs, presumptive al-
ternative splice forms of both GRIP1 and ABP-L/GRIP2 were
noted that contained small insertions or deletions at certain sites
in both cDNA sequences (data not shown). The particular splice
variant of ABP-L/GRIP2 protein shown in Figure 1 is 1002
amino acids long and has a predicted Mr of 107,733.
By Northern analysis, ABP-L/GRIP2 mRNA is expressed pre-
dominantly in the brain, in the form of a major ;6 kb transcript
and a minor ;2.8 kb transcript (Fig. 1, inset). Similar-size mR-
NAs were present in the heart, but less abundantly. ABP-L/
GRIP2 mRNAs of smaller size were detected in liver (;2.4 kb)
and in testis (;1 kb). Thus ABP-L/GRIP2 mRNA shows a tissue
expression pattern distinct from GRIP1, which is predominantly
expressed in brain and testis and expressed at a low level in
kidney (Wyszynski et al., 1998).
Ultrastructural localization of GRIP protein in rat brain
Two different polyclonal rabbit antisera were raised against fu-
sion proteins containing PDZ6 through the C terminus of GRIP1
and affinity-purified (Wyszynski et al., 1998). The affinity-purified
antibodies (termed 1756 and C8399-I; see Materials and Meth-
ods) specifically and effectively recognize both GRIP1 and ABP-
L/GRIP2, as assessed by immunoblotting of recombinant bacte-
rial fusion proteins and rat brain extracts (Wyszynski et al., 1998;
data not shown). The cross-reactivity of 1756 and C8399 antibod-
ies is not surprising, because the PDZ6 and PDZ7 domains are
highly conserved between GRIP1 and ABP-L/GRIP2 (Fig. 1).
Although unable to distinguish between GRIP1 and ABP-L/
GRIP2, these antibodies are nevertheless specific for GRIP and
hence useful for probing the set of GRIP1 and ABP/GRIP2
proteins in the brain. Using these “pan-GRIP” antibodies, we
have recently described the immunohistochemical localization of
GRIP in various regions of rat brain (Wyszynski et al., 1998). At
the light microscopy (LM) level, GRIP is widely distributed
within brain neurons, showing a punctate staining pattern on top
of a diffuse intracellular labeling (Wyszynski et al., 1998).
To obtain higher resolution, we studied the subcellular local-
ization of GRIP by postembedding immunogold electron micros-
copy (EM) of adult rat neocortex (Fig. 2). A similar labeling
pattern was seen using two GRIP antibodies prepared from
different rabbits and purified in different ways (C8399-I and 1756),
supporting the specificity of immunogold labeling. In all blocks,
the highest density of gold particles coding for GRIP was associ-
ated with asymmetric synapses (Fig. 2 A,D, E). Labeled symmet-
ric synapses were rare; of 114 labeled synapses studied in three
rats, only 2 were symmetric. Labeling (at a lower level density)
could also be seen over nonsynaptic plasma membranes (Fig.
2B,C). Considerable intracellular labeling was present within
spines and within dendritic shafts (Fig. 2 C, F); in dendritic shafts
particles were typically associated with microtubules (Fig. 2F). In
some cases, GRIP immunoreactivity was seen in axons, axon
terminals, and somatic endoplasmic reticulum (data not shown).
Thus based on immuno-EM, GRIP is present at excitatory syn-
apses but additionally associated with nonsynaptic membranes
and intracellular compartments.
The synaptic labeling for GRIP was concentrated over the
postsynaptic membrane and the postsynaptic density and was
generally sparser over the presynaptic profile. Approximately
one-third (87 of 266) of asymmetric synapses were labeled for
GRIP. This is probably an underestimate, considering the limited
sensitivity of the method and our use of single, rather than serial,
sections to assess each synapse. To quantify the staining pattern
at synapses, we measured the distributions of gold particles asso-
ciated with synapses in 70 randomly selected fields from three
animals. Along the axodendritic axis, particle density was highest
at the postsynaptic membrane with some spread (up to 150 nm)
toward the presynaptic and postsynaptic compartments (Fig. 2G).
The labeling density appeared higher at the center of the active
zone, declining toward the edge of the PSD (Fig. 2H).
Localization of GRIP in cultured hippocampal neurons
We also assessed the cellular and subcellular localization of
GRIP by immunocytochemistry of hippocampal neurons in low-
density culture (Fig. 3A–D). A similar labeling pattern was seen
using anti-GRIP antibodies 1756 and C8399-I. GRIP showed fine
punctate and diffuse staining in cell bodies and dendrites (Fig.
3A–D). In addition, GRIP appeared to be concentrated in sparse
puncta of larger diameter (0.5–2 mm) along the somata and
dendrites of many neurons (Fig. 3B,C). Double-label immunocy-
tochemistry with GRIP 1756 and synaptophysin antibodies re-
vealed GRIP localization to a subset of synaptic sites (Fig. 3A). A
large fraction of the GRIP puncta, however, appeared
nonsynaptic.
Double labeling with 1756 and anti-GluR2 antibodies showed
extensive overlap of GRIP and AMPA receptor staining in cell
bodies and major dendritic shafts but only limited colocalization
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of GRIP and GluR2 in dendritic puncta [;10% of GluR2 puncta
colocalized with GRIP along dendrites (Fig. 3B, arrowheads)].
On the other hand, double labeling with 1756 antibodies and an
antibody against GAD, to reveal inhibitory presynaptic sites,
showed extensive colocalization of GRIP and GAD in the larger
puncta, although colocalization was not complete (Fig. 3C). In-
terestingly, diffuse cytoplasmic GRIP immunoreactivity was also
much higher in GABAergic neuronal somata and their processes
than in pyramidal neurons (Fig. 3D). Association of GRIP with
inhibitory neurons and synapses has also been observed with
independent GRIP antibodies (R. L. Huganir, personal commu-
nication). Overall, the pattern of immunostaining in embryonic
hippocampal cultures indicated that GRIP is highly expressed in
GABAergic neurons and enriched in inhibitory nerve terminals.
The nature of the nonsynaptic GRIP staining is unclear, but it is
consistent with the GRIP labeling of nonsynaptic membranes and
intracellular compartments seen by EM (Fig. 2). Earlier biochem-
ical fractionation had also suggested a widespread subcellular
distribution of GRIP (Wyszynski et al., 1998).
Immunocolocalization of GRIP and GAD was confirmed in
vivo by double labeling of rat brain (for detailed information on
the pattern of cellular labeling, see Burette et al., 1999). Punctate
GRIP staining in the neuropil of rat brain is greatly enhanced by
light protease treatment of the sections. In hippocampus a subset
of these GRIP immunoreactive puncta colocalized with GAD-
positive puncta on cell bodies and proximal dendrites of pyrami-
dal neurons (Fig. 3E), consistent with the localization of GRIP in
inhibitory synapses. Unfortunately, the protease digestion was
incompatible with synaptophysin staining; thus we were unable to
perform double labeling to test whether the GRIP puncta in
general were synaptic in brain sections (data not shown).
Association of GRIP and AMPA receptors in vivo
Although our immuno-EM data revealed the presence of GRIP
at excitatory synapses in rat brain, it does not prove that GRIP is
biochemically associated with AMPA receptors at these sites. To
test whether GRIP and AMPA receptors exist in a protein
complex, we optimized a coimmunoprecipitation assay that al-
lowed us to immunoprecipitate GRIP or AMPA receptor sub-
units virtually quantitatively from detergent extracts prepared
from rat brain membranes (Fig. 4A). Because our antibodies
recognize both GRIP1 and ABP/GRIP2, we can assess AMPA
receptor association with the entire known family of GRIP
proteins.
Our extraction conditions using deoxycholate detergent solubi-
lized the large majority of GRIP and AMPA receptors (typically
.80%; Fig. 4A). Using GRIP antibodies for immunoprecipita-
tion, close to all of the extracted GRIP could be pelleted with the
protein A-Sepharose beads, leaving little or undetectable
amounts of GRIP in the supernatant (Fig. 4B, compare row A,
lanes 8, 9). This GRIP immunoprecipitate contained most of the
GluR2/3 in the extract, leaving behind a minor fraction of
GluR2/3 in the supernatant (Fig. 4B, row B, lanes 8, 9). In
multiple experiments, the fraction of GluR2/3 that was coimmu-
noprecipitated with GRIP ranged from ;40 to ;80%. Further-
more, approximately half of the extracted GluR1 (an AMPA
receptor subunit that does not bind directly to GRIP) was coim-
munoprecipitated with GRIP (Fig. 4B, row C, lanes 8, 9). Control
experiments showed that the NMDA receptor subunit NR1 and
PSD-95 were not coimmunoprecipitated with GRIP antibodies
(Fig. 4B, rows D, E, lane 8). Because PSD-95 can be efficiently
coimmunoprecipitated with NR1 under the same conditions (data
not shown), this result indicates that GRIP-GluR2/3-containing
complexes are distinct from complexes containing NR1 and
PSD-95.
In the converse reaction, GluR2/3 antibodies were able to
quantitatively immunoprecipitate GluR2/3 from the extract and
to coimmunoprecipitate approximately half of the extracted
GRIP protein (Fig. 4B, rows A, B, lanes 11, 12; data not shown).
In multiple experiments, the fraction of GRIP that was coimmu-
noprecipitated with GluR2/3 ranged from ;30 to ;50%. The
same immunoprecipitates contained a majority of the GluR1
(Fig. 4B, row C, lanes 11, 12). Again, the GRIP-GluR2/3 coim-
munoprecipitation is specific, because no detectable NR1 and
PSD-95 was pelleted with GluR2/3 (Fig. 4B, rows D, E, lane 11).
In further negative controls, equal amounts of nonspecific rabbit
immunoglobulins or heat-inactivated GRIP antibodies were un-
able to precipitate GRIP, GluR2/3, GluR1, NR1, or PSD-95 (Fig.
4B, rows A–E, lanes 2, 5). Similar results were reproduced in
several experiments.
We also used an independent antibody (GluR2-N) directed
against the extracellular N-terminal region of GluR2 to perform
the immunoprecipitation (Fig. 4C). GluR2-N immunoprecipi-
tated approximately half of the GluR2/3 and GluR1 immunore-
activity from the brain extract, consistent with the association of
these subunits in heteromeric AMPA receptors (Fig. 4C, rows B,
C, lanes 2, 3). A significant fraction of GRIP was specifically
coimmunoprecipitated with GluR2-N antibodies (Fig. 4C, row A,
lanes 2, 3). However, no detectable NR1 and PSD-95 was pelleted
with GluR2-N (Fig. 4C, rows D, E, lane 2). Thus using multiple
antibodies we could show substantial association of AMPA re-
ceptors and GRIP in adult rat brain.
If the immunoprecipitation of GRIP-AMPA receptor subunit
complexes from brain detergent extracts was attributable to arti-
factual association of these proteins occurring after solubiliza-
tion, a synthetic peptide comprising the last 10 residues of the
GluR2/3 C terminus should compete for PDZ domain binding
and hence should reduce or abolish the coimmunoprecipitation of
GRIP and GluR2/3 by competing for binding to the GRIP PDZ
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Figure 2. EM photomicrographs of immunogold labeling (18 nm gold particles) for GRIP in layers II /III of rat somatic sensory cortex. A, Gold particles
(arrowheads) label two asymmetric synapses made by the same terminal onto spines. B, GRIP immunogold labeling (arrowheads) at nonsynaptic sites
of the plasma membrane of two spines. C, Gold particles labeling the postsynaptic membrane of a perforated synapse with additional intracellular
labeling within the dendritic spine (arrow). D, Gold particle labeling encroaches into the presynaptic cytoplasm (arrow); the postsynaptic labeling
(arrowhead) coincides with the “inner” margin of the PSD. E, Immunogold labeling (arrowhead) at an asymmetric synapse extends into the postsynaptic
cytoplasm. F, Large dendritic profile immunopositive for GRIP; arrows point to labeling adjacent to microtubules. Sp, Spine; asterisks mark presynaptic
terminals. Scale bars: A–D, 0.25 mm; E, F, 0.5 mm. G, H, Quantitative analysis of the distribution of GRIP immunogold particles at the synapse. G,
Distribution of gold particles in the axodendritic axis. One hundred sixty particles lying within 175 nm of the postsynaptic membrane were measured
in 70 random electron micrographic fields, selected to reveal clear synaptic membranes; data were pooled from three animals. Abscissa, Distance from
the center of each gold particle to the postsynaptic membrane (in nanometers); ordinate, labeling density (arbitrary units); zero density corresponds to
the x-axis. H, Lateral distribution of gold particles along the synapse (only those within 100 nm of the postsynaptic membrane were considered). Lateral
position is normalized; center of the active zone corresponds to 0; and edge corresponds to 1.0.
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domain. However, even in the presence of a 0.5 mM concentration
of GluR2/3 C-terminal peptide, GluR2/3 showed equally substan-
tial coimmunoprecipitation with GRIP (Fig. 4D). These results
indicate that AMPA receptor subunits are largely associated with
GRIP in native complexes in rat brain, but that a significant
fraction of GRIP is not associated with AMPA receptors.
GRIP and GluR2/3 were also coimmunoprecipitated from ju-
venile rat brain (postnatal day 7) with similar efficiency to adult,
indicating that GRIP and AMPA receptors are highly associated
in immature brain. However, in neuronal culture (3 weeks in
culture), we found poor association (,10%) of GRIP and AMPA
receptor subunits by coimmunoprecipitation (data not shown).
This poor coimmunoprecipitation in cultured neurons correlates
with the weak colocalization of GRIP and GluR2 seen by immu-
nocytochemistry (Fig. 3).
DISCUSSION
ABP and ABP-L/GRIP2 are splice variants of the
same gene
ABP, a GluR2/3-binding protein with six PDZ domains, has been
recently reported (Srivastava et al., 1998). Based on sequence
comparisons with the ABP-L/GRIP2 protein described here,
ABP and ABP-L/GRIP2 are almost certainly alternative splice
variants of the same gene. ABP is a splice form that has been
truncated at the C-terminal region, thereby losing the seventh
PDZ domain. The reported size of ABP on SDS-PAGE matches
the minor 97 kDa band that we detect consistently with our
pan-GRIP antibodies (Wyszynski et al., 1998); furthermore, Sriv-
astava et al. (1998) also reported higher molecular weight bands
on their ABP Western blots that probably correspond, at least in
Figure 3. Immunocytochemical localization of GRIP in cultured hippocampal neurons and in rat brain. A–E, Double-label immunocytochemistry of
hippocampal neurons (3 weeks in low-density culture) with antibodies to GRIP (1756, A–D) and synaptophysin (Syp, A), GluR2 (B), or glutamic acid
decarboxylase (GAD, C, D). GRIP is visualized by Cy3 secary antibody (red), and synaptophysin, GluR2, and GAD are visualized by FITC secondary
antibody ( green). Colocalization is shown in yellow. A subset of GRIP-immunoreactive puncta showed colocalization with synaptophysin (A) and GluR2
(B). Inset, Enlargement of the boxed region in B, showing examples of GRIP/GluR2 colocalization in dendritic spine-like structures (arrowheads). There
is also extensive overlap of GRIP and GluR2 staining in the cell body (B). The larger GRIP puncta colocalized with a subset of GAD-labeled inhibitory
terminals ( C). GABAergic neurons also had higher levels of diffuse somatodendritic GRIP immunoreactivity than did pyramidal neurons ( D). E,
Confocal image showing partial colocalization of GRIP and GAD in area CA1 of hippocampus. Note colocalized immunoreactive puncta on pyramidal
cell bodies and adjacent neuropil. p, Stratum pyramidale; so, stratum oriens. Scale bars: A, D, 10 mm (for A–D); E, 40 mm.
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part, to “full-length” ABP-L/GRIP2 polypeptides. It will be of
interest to identify the binding partners of PDZ7 in GRIP,
because its absence in ABP implies that the function of PDZ7 can
be uncoupled from that of the other six PDZ domains. The
significance of the alternative splicing of ABP/ABP-L/GRIP2
remains to be determined.
A major fraction of GluR2/3 is associated with GRIP
The binding of GluR2/3 to GRIP has been previously studied
only in vitro and in heterologous expression systems (Dong et al.,
1997; Srivastava et al., 1998). We show here that AMPA receptor
subunits are associated with GRIP in vivo. Indeed, a major
fraction of GluR2/3 appears to be complexed with GRIP in the
brain under optimal conditions for immunoprecipitation. Approx-
imately half of the extractable GluR1 is also associated with
GRIP, presumably via heteromultimerization with GluR2/3, be-
cause GluR1 cannot bind directly to the PDZ domains of GRIP.
That a lesser fraction of GluR1 than of GluR2/3 is associated with
GRIP in rat brain cortex may be accounted for in part by the
existence of AMPA receptors that contain GluR1 but not
GluR2/3 (Martin et al., 1993; Kharazia et al., 1996; Wenthold et
al., 1996; Kondo et al., 1997). When it is not in a heteromeric
configuration with GluR2/3, GluR1 may be associated with scaf-
fold proteins other than GRIP. It is intriguing, given that much of
GluR1 appears not to be complexed with GRIP, that a recent
report showed GluR1 to be coimmunoprecipitated with SAP97, a
PSD-95-related protein (Leonard et al., 1998).
Although most of the extractable GluR2/3 is complexed with
GRIP, a substantial proportion of GRIP appears not to be
Figure 4. Coimmunoprecipitation of na-
tive complexes containing GRIP and
AMPA receptor subunits from rat brain.
A, Detergent solubility of GRIP and
AMPA receptor subunits. Crude synapto-
somal membrane fraction from rat cortex
was extracted with sodium deoxycholate
(DOC); equal percentages of the resulting
extract (Sol ) and pellet fractions were im-
munoblotted for GRIP, GluR2/3, GluR1,
NR1, and PSD-95. B, Membrane proteins
from adult rat cortex were detergent-
solubilized as described in Materials and
Methods. Parallel samples of brain extract
were immunoprecipitated (IP) with non-
specific rabbit IgGs or affinity-purified an-
tibodies to GRIP or GluR2/3, as indi-
cated. In lanes 4–6, the GRIP antibodies
were heat-inactivated by boiling before
use. Each immunoprecipitation experi-
ment is shown in three lanes: I, input to the
immunoprecipitation reaction; P, immu-
noprecipitated pellet; and S, supernatant
remaining after the immunoprecipitation.
Equal fractions of each sample (;10%)
were loaded, thus allowing direct estimate
of the fraction of each protein immuno-
precipitated (the amount of protein in I 5
P 1 S). The I, P, and S fractions of the
various immunoprecipitation reactions
were immunoblotted (IB) for GRIP,
GluR2/3, GluR1, NR1, and PSD-95, as
indicated to the right of each row. Rows
are also labeled (A–E) for reader orienta-
tion (see Results). C, D, Same as for B,
except that GluR2-N antibodies were used
for immunoprecipitation in C, and solubi-
lization and immunoprecipitation was
performed in the presence of either
GluR2/3 or NR2B C-terminal competitor
peptide (0.5 mM final concentration) in D.
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associated with GluR2/3. The simplest interpretation of this ob-
servation is that AMPA receptors interact with only a subset of
GRIP in the brain. The remaining fraction of GRIP may be
involved in the assembly of protein complexes that do not include
AMPA receptor subunits.
Several findings support the idea that GRIP may play addi-
tional roles unrelated to the anchoring of AMPA receptors at
synapses. First, GRIP is only modestly enriched in synaptic or
PSD fractions when compared with PSD-95, the prototypical
postsynaptic scaffold protein (Wyszynski et al., 1998). Second,
significant amounts of GRIP are present in subcellular fractions
that are depleted of synaptic membranes, such as the cytosolic
fraction S3 and the synaptic vesicle-enriched fraction LP2
(Wyszynski et al., 1998). Third, although immunogold EM shows
a concentration of GRIP at asymmetric synapses in adult brain
neurons, it also reveals GRIP immunoreactivity at nonsynaptic
membranes and in intracellular compartments of dendritic spines
and shafts. Fourth, immunocytochemistry of cultured embryonic
neurons from hippocampus reveals that a prominent signal for
GRIP is in GABAergic neurons and their nerve terminals, and a
large fraction of GRIP immunoreactivity is nonsynaptic. Finally,
GRIP expression is high very early during cortical development
and does not correlate temporally with AMPA receptor expres-
sion or synaptogenesis (Wyszynski et al., 1998). Taken together,
these data argue that a large proportion of GRIP is not associated
with excitatory synapses, where AMPA receptors are presumed
to be concentrated. Perhaps this nonsynaptic fraction of GRIP is
represented by the subset of GRIP that does not coimmunopre-
cipitate with GluR2/3. Based on the precedent of PSD-95, it is
quite likely that there are multiple binding partners for each
individual PDZ domain of GRIP. Thus at synaptic sites, GRIP
may be complexed with AMPA receptors, whereas at nonsynaptic
sites, GRIP may be complexed with a different set of interacting
proteins. It is also possible that the GRIP–AMPA receptor
interaction occurs only after both proteins reach the synapse, in
which case the nonsynaptic GRIP may be in an unbound (AMPA
receptor-free) form in transit to its final location.
The above discussion is prejudiced toward the idea that AMPA
receptors are highly concentrated in excitatory postsynaptic mem-
branes, and that the site of GluR2/3-GRIP interaction is primar-
ily at synaptic sites. However, to reach their synaptic destination,
AMPA receptor proteins themselves have to be sorted via specific
vesicle trafficking pathways emanating from the cell body. Fur-
thermore, recent evidence points to a regulated trafficking of
AMPA receptors at postsynaptic sites and the existence of intra-
cellular and subsynaptic pools of AMPA receptor subunits (Mol-
nár et al., 1993; Baude et al., 1995; Nusser et al., 1998; Petralia et
al., 1999). These considerations imply the existence of AMPA
receptor proteins residing in intracellular membranous compart-
ments on the way to, and in the vicinity of, the synapse. Consis-
tent with this, we note that the staining pattern of AMPA recep-
tors in neurons is typically more diffuse than that of NMDA
receptors, suggesting a more widespread subcellular distribution
for AMPA receptors (Rao et al., 1998). If GluR2/3 subunits are as
highly associated with GRIP as the coimmunoprecipitations
would suggest, then it is possible that some of the nonsynaptic
GRIP that we observe is complexed with intracellular pools of
AMPA receptors. Thus GRIP could play a role in AMPA recep-
tor trafficking in addition to its function in synaptic anchoring of
AMPA receptors. In this regard, it will be important to determine
at what stage of the secretory pathway the GRIP-GluR2/3 inter-
action takes place.
Localization of GRIP in GABAergic neurons
and terminals
A surprising finding was that in hippocampal neuron cultures
GRIP immunoreactivity colocalized more prominently with
GAD, a marker of GABAergic neuronal somata and terminals,
than with AMPA receptors. The association of GRIP with
GABAergic neurons in culture is consistent with immunohisto-
chemistry of rat brain sections, which showed the most striking
expression of GRIP protein in interneurons of hippocampus and
cortex (Wyszynski et al., 1998). The immunostaining pattern in
cultured neurons indicates the enrichment of GRIP in GABAer-
gic somata and dendrites and nerve terminals. A partial colocal-
ization of GRIP- and GAD-immunoreactive puncta was also
seen in brain by confocal microscopy, supporting the idea that
GRIP is concentrated in GABAergic presynaptic terminals in
vivo. The particularly abundant expression of GRIP in GABAer-
gic neurons is of interest. GABAergic interneurons contain
AMPA receptor clusters that are more insoluble in Triton X-100
than AMPA receptors in pyramidal cells (Allison et al., 1998).
Moreover, relative to pyramidal neurons, GABAergic neurons
show a particularly high content and low variability of AMPA
receptors at excitatory postsynaptic sites (Nusser et al., 1998).
Whether these postsynaptic characteristics are related to the high
levels of GRIP in these neurons remains to be determined.
Synthesis of LM and EM findings: multiple pools
of GRIP
In contrast to LM immunocytochemistry of hippocampal cul-
tures, we did not observe a concentration of GRIP signal over
nerve terminals at symmetric (presumed inhibitory) synapses by
immuno-EM of neocortex. Instead, the highest density of GRIP
labeling occurred over asymmetric synapses, as might be expected
for an AMPA receptor-binding protein. We are confident of the
specificity of each staining pattern because they were consistently
obtained with multiple independent GRIP antibodies in appro-
priately controlled experiments. The apparently different results
in hippocampal culture and adult rat neocortex may reflect dif-
ferent developmental stages of these preparations and/or the
differential strengths and weakness of LM versus postembedding
EM immunolocalization. The postembedding immunogold EM
technique is especially sensitive to the density of the antigen and
may miss antigens that are relatively soluble and easily lost during
the processing of the thin sections (such as may occur for GRIP
in GABAergic nerve terminals). The accessibility or “visibility”
of the antigen may also vary with the different methods. Proteins
in the PSD may be less accessible to antibodies and often are
more difficult to stain by LM immunohistochemistry than the
same proteins in cytoplasmic compartments (e.g., see Watanabe
et al., 1998). In support of this, we found that punctate GRIP
staining in the brain at the LM level is dramatically revealed by
protease treatment of brain sections. On the other hand, the thin
sectioning of postembedding immuno-EM can directly reveal
antigens in hard-to-access places like the PSD.
Alternatively, it is possible that real differences exist between
the subcellular distribution of GRIP in hippocampal culture and
in the intact brain. In particular, we note that in contrast to the
brain, GRIP and AMPA receptor subunits are poorly associated
in neuron cultures, as assessed by coimmunoprecipitation. This
correlates with the limited colocalization of GRIP and AMPA
receptor subunits at synaptic puncta in cultured neurons. In this
sense, cultured hippocampal neurons may represent an imperfect
model for GRIP–AMPA receptor interactions.
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Because of the apparent discrepancies discussed above, it is
important to synthesize the results from multiple immunohisto-
chemical approaches and to combine them with more quantitative
biochemical fractionation studies. By doing this, we conclude that
multiple pools of GRIP exist in neurons spread among several
subcellular locations. GRIP is not only present at the excitatory
postsynaptic membrane; it is also at inhibitory synapses and in
intracellular compartments close to and distant from the synapse.
Moreover, only approximately half of GRIP is associated with
AMPA receptors. The future challenge will be to define the
molecular roles played by these various different subsets of GRIP
and to relate these functions to the trafficking and function of
AMPA receptors.
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